Cisplatin has long been considered the standard first-line chemotherapy of choice for cervical cancer patients demonstrating disease recurrence.
Article Limit Reached
You have reached your article limit for the month. Subscribe now to access this article plus other member-only content.
- Award-winning Medical Content
- Latest Advances & Development in Medicine
- Unbiased Content